Multifaceted leptin network: the molecular connection between obesity and breast cancer.
High plasma levels of leptin, a major adipocytokine produced by adipocytes, are correlated with increased fat mass in obese state. Leptin is emerging as a key candidate molecule linking obesity with breast cancer. Acting via endocrine, paracrine, and autocrine manner, leptin impacts various stages of breast tumorigenesis from initiation and primary tumor growth to metastatic progression. Leptin also modulates the tumor microenvironment mainly through supporting migration of endothelial cells, neo-angiogenesis and sustaining recruitment of macrophage and monocytes. Various studies have shown that hyperactive leptin-signaling network leads to concurrent activation of multiple oncogenic pathways resulting in enhanced proliferation, decreased apoptosis, acquisition of mesenchymal phenotype, potentiated migration and enhanced invasion potential of tumor cells. Furthermore, the capability of leptin to interact with other molecular effectors of obese state including, estrogen, IGF-1, insulin, VEGF and inflammatory cytokines further increases its impact on breast tumor progression in obese state. This article presents an overview of the studies investigating the involvement of leptin in breast cancer.
Department of Medicine, University of Maryland School of Medicine, 660 W Redwood St., Howard Hall, Rm 301, Baltimore, MD, 21201, USA, nsaxena@medicine.umaryland.edu.
Neeraj K
NK
Saxena
Dipali
D
Sharma
D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism / Q000503:physiopathology*; D005260:Female; D006801:Humans; D020738:Leptin / Q000502:physiology*; D009765:Obesity / Q000378:metabolism / Q000503:physiopathology*; D054411:Receptors, Leptin / Q000378:metabolism; D012307:Risk Factors; D015398:Signal Transduction
D020738:Leptin; D054411:Receptors, Leptin